Selbyville, Delaware, Oct. 27, 2022 (GLOBE NEWSWIRE) --
The sleep apnea devices market value is anticipated to exceed USD 14.5 billion by 2030, according to a new research report by Global Market Insights Inc.
Surging availability of insurance coverage for the treatment of sleep apnea and other sleep disorders will drive industry expansion. Some insurance providers also cover certain devices like MADs and the cost of continuous positive airway pressure (CPAP) therapy. In September 2022, ProSomnus, a pioneer in precision medical devices for obstructive sleep apnea (OSA) treatment, announced that its EVO Sleep and Snore Device, an alternative to traditional oral devices and CPAP machines, had become reimbursable by Germany's public health insurance system.
Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/489
Rising uptake of CPAP devices to boost sleep apnea devices market size
Therapeutics segment is projected to grow steadily through the analysis period owing to the soaring adoption of CPAP treatment, which is regarded as the gold standard therapy for relieving blockage in the upper airway during sleep. Moreover, the high prevalence of OSA is a growing public health concern, which is bolstering product demand. In addition, the availability of alternatives for therapeutic devices and treatment modalities for sleep disorders is slated to increase market share.
Browse key industry insights spread across 177 pages with 231 market data tables & 14 figures & charts from the report, “Sleep Apnea Devices Market Analysis By Product (Therapeutics {Airway Clearance System, Adaptive Servo-ventilation {ASV}, Positive Airway Pressure {PAP} Device, Oral Appliances, Oxygen Devices}, Diagnostics {Actigraphy Systems, Polysomnography {PSG} Device, Respiratory Polygraph, Sleep Screening Devices}), By End-use (Home Care Settings & Individuals, Sleep Laboratories & Hospitals), Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2022 – 2030” in detail along with the table of contents:
https://www.gminsights.com/industry-analysis/sleep-apnea-devices-market-report
Growing inclination toward at-home treatments to enhance home care settings & individuals segment outlook
Home care settings & individuals segment is estimated to surpass USD 8 billion by 2030. The superior efficiency and convenience of at-home sleep testing have impelled product adoption in home settings. Growing preference for at-home testing and treatment has benefitted. The mounting access to direct-to-consumer at-home diagnostics is set to further stimulate segment progress.
High prevalence of sleep disorders to propel Europe market progression
Europe sleep apnea devices market is speculated to expand at a more than 7% growth rate through the forecast period. Sleep disorders are becoming more common in the region as a result of escalating anxiety and psychological distress, which is negatively affecting consumer lifestyles. The growing demand for minimally invasive treatments, as well as the rapid adoption of technologically advanced medical equipment, is likely to advance product demand in the region.
Product development by prominent players to strengthen the market scenario
The industry consists of Fisher & Paykel Healthcare, Koninklijke Philips N.V., Invacare Corporation, ResMed Inc., Natus Medical Inc., and Teleflex Inc., among other firms.
Request for customization of this research report @ https://www.gminsights.com/roc/489
About Global Market Insights
Global Market Insights Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy, and biotechnology.
